Financials
Financial year 2025
Revenue
€ 2.2 million
▲ 1% vs 2023
Profit
Healthy€ 11.1 million
▼ 32% vs 2023
Debts
Low€ 1,011.9 million
▲ 31% vs 2023
Perrigo Capital from Gent, company number BE0430784027, closed financial year 2025 with a result of € 11.1 million after tax. For that financial year Perrigo Capital recorded revenue of € 2.2 million and equity of € 565.9 million. Compared with financial year 2023, the result moved from € 16.3 million to € 11.1 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
What happened at Perrigo Capital?
What happened at Perrigo Capital in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jonas Dhaenens stepped down as director. NBB
- Sonia Hollies stepped down as director. NBB
- Magali Verbraeken stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 11.1 million (▼ 32% vs 2023). Source: NBB ↗
- Anja van Winsberghe stepped down as director. NBB
- Jonas Dhaenens became a director. NBB
- Sonia Hollies became a director. NBB
- Magali Verbraeken became a director. NBB
In short
From € 7.7 million profit in 2021 to € 11.1 million profit in 2025.
Paid € 11.5 million in corporate taxes since 2021.
Best year ever: 2023, with € 16.3 million profit.
Pays suppliers within 100 days on average.
A new publication or filing at Perrigo Capital? We notify you, reason included.
Follow Perrigo CapitalNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Omega Pharma GmbH (55.1%) and Perrigo Holding NV (44.9%). It owns 79.9% of Perrigo Belgium itself.
Directors
According to the 2025 annual accounts
Magali Verbraeken
Director
Also active at: MEDGENIX BENELUX, OMEGA PHARMA TRADING, Perrigo Belgium +5 more
since 2023 · until 2029
Anja van Winsberghe
Director
Also active at: MEDGENIX BENELUX, OMEGA PHARMA TRADING, Perrigo Belgium +7 more
since 2021 · until 2026
Sonia Hollies
Director
Also active at: Perrigo Europe Invest, OMEGA PHARMA INTERNATIONAL, OMEGA PHARMA INNOVATION & DEVELOPMENT
since 2024 · until 2030
Jonas Dhaenens
Director
Also active at: OMEGA PHARMA TRADING, Perrigo Holding, Perrigo Europe Invest +3 more
since 2026 · until 2032
Shareholders
Omega Pharma GmbH
55.1%
44.9%
Participations
79.9%
Establishments
Establishment units
Physical locations of this company
Gaston Crommenlaan 6 box 606
9050 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
OMEGA PHARMA TRADING same network
€ 538,596 revenue · 2025
Perrigo Belgium same network
€ 44.6 million revenue · 2025
Perrigo Holding same network
€ 48.4 million revenue · 2025
Perrigo Europe Invest same network
Oce-Bio same network
€ 4.1 million revenue · 2025
+9 more
Details
- Company number
- 0430.784.027
- VAT number
- BE 0430.784.027
- Registered office
- Gaston Crommenlaan 6 bus 606, 9050 Gent
- Names & denominations
- Perrigo Capital
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 25 March 1987
- Peppol
- Active · Active since 8 Dec 2025
- Activities · NACE
Activiteiten van holdings
Managementactiviteiten van holdings
Groothandel in koffie, thee, cacao en specerijen
Holdings
Vervaardiging van andere voedingsmiddelen, neg
Vervaardiging van overige voedingsmiddelen, n.e.g.